share_log

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144: Notice of proposed sale of securities pursuant to Rule 144

Teladoc Health | 144：擬議出售證券
美股sec公告 ·  04/30 04:17
牛牛AI助理已提取核心訊息
Jason Gorevic, former CEO of Teladoc Health Inc, is set to sell 448,225 common shares of the company on April 29, 2024. The shares to be sold have an aggregate market value of approximately $5.83 million. These shares were acquired by Gorevic as compensation over several years, with the earliest acquisition dating back to March 11, 2013, and the most recent on March 2, 2023. The transactions over the years have included significant amounts of shares, reflecting Gorevic's compensation package during his tenure with the company. There is no recent sale history reported for the past three months prior to the notice date.
Jason Gorevic, former CEO of Teladoc Health Inc, is set to sell 448,225 common shares of the company on April 29, 2024. The shares to be sold have an aggregate market value of approximately $5.83 million. These shares were acquired by Gorevic as compensation over several years, with the earliest acquisition dating back to March 11, 2013, and the most recent on March 2, 2023. The transactions over the years have included significant amounts of shares, reflecting Gorevic's compensation package during his tenure with the company. There is no recent sale history reported for the past three months prior to the notice date.
Teladoc Health Inc前首席執行官傑森·戈雷維奇定於2024年4月29日出售該公司的448,225股普通股。待售股票的總市值約爲583萬美元。戈雷維奇在幾年內以補償方式收購了這些股份，最早的收購可以追溯到2013年3月11日，最近一次收購是在2023年3月2日。多年來的交易包括大量股份，反映了戈雷維奇在公司任職期間的薪酬待遇。在通知日期之前的過去三個月中，沒有報告最近的銷售記錄。
Teladoc Health Inc前首席執行官傑森·戈雷維奇定於2024年4月29日出售該公司的448,225股普通股。待售股票的總市值約爲583萬美元。戈雷維奇在幾年內以補償方式收購了這些股份，最早的收購可以追溯到2013年3月11日，最近一次收購是在2023年3月2日。多年來的交易包括大量股份，反映了戈雷維奇在公司任職期間的薪酬待遇。在通知日期之前的過去三個月中，沒有報告最近的銷售記錄。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。